Adult liver transplantation at UCL: update 2002.

Détails

ID Serval
serval:BIB_62E39DD24149
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Adult liver transplantation at UCL: update 2002.
Périodique
Acta Gastro-enterologica Belgica
Auteur(s)
Lerut J., Matthys J., Lemaire J., Van Thuyne V., Ciccarelli O., Goffette P., Peeters A., Aunac S., Boddeus M., Carlier M.A., Danse E., De Kock M., De Reyck C.h., Donataccio M., Geubel A., Gonze D., Goubau P., Latinne D., Laterre P.F., Luts A., Cool G., Otte J.B., Horsmans Y., Martinez J., Orlando G., Rahier J., Reding R., Reynaert M., Starkel P., Sempoux C.h., Talpe S., Van Obbergh L., Veyckemans F., Wallemacq P., Wittebolle X., Roggen F.
ISSN
1784-3227 (Print)
ISSN-L
1784-3227
Statut éditorial
Publié
Date de publication
2004
Peer-reviewed
Oui
Volume
67
Numéro
2
Pages
188-196
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Résumé
The authors present the results of a single centre study of 587 liver transplants performed in 522 adults during the period 1984-2002. Results have improved significantly over time due to better pre-, peri- and post-transplant care. One, five, ten and fifteen year actuarial survivals for the whole patient group are 81.2; 69.8; 58.9 and 51.2%. The high incidence of de novo tumors (12.3%), of cardiovascular diseases (7.5%) and of end-stage renal function (3.6%) should be further incentives to tailor the immunosuppression to the individual patient and to direct the attention of the transplant physician to the long-term quality of life of the liver recipient.
Mots-clé
Adult, Humans, Immunosuppressive Agents/therapeutic use, Liver Transplantation, Survival Analysis, Treatment Outcome
Pubmed
Web of science
Création de la notice
20/10/2016 17:23
Dernière modification de la notice
20/08/2019 15:19
Données d'usage